Eagle's Eye View: Your Weekly CV Update From ACC.org

Dive into groundbreaking cardiovascular research from the recent conference in Chicago. Discover how TAVR compares to surgical aortic valve replacement with impressive five-year results. Learn about the advantages of clopidogrel over aspirin after a PCI and how dapagliflozin benefits older heart failure patients during valve procedures. Plus, see how semaglutide enhances outcomes for peripheral artery disease. Rivaroxaban shines in post-MI settings, alongside innovative dosing strategies for anticoagulants in active cancer patients.

In this week’s View, Dr. Eagle looks at the latest clinical guidance on the management of cardiogenic shock. He then discusses trends in mortality after mitral repair and TAVR. Finally, Dr. Eagle offers a brief exploration into how direct-to-physician industry marketing affects rates of guideline-directed medical therapy (GDMT) surrounding heart failure patients.    Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle examines the dose-response relationship between smoking and subclinical cardiovascular disease markers. He then discusses how the effect of poor sleep increases diabetes risk in women who have had gestational diabetes. Finally, Dr. Eagle offers a look into imaging post-transcatheter aortic valve replacement (TAVR) in patients who may have valve failure.    Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle looks at a sex-based analysis of short-term dual antiplatelet therapy (DAPT) in patients receiving percutaneous coronary intervention (PCI) who are deemed at high-risk for bleeding. He then discusses the potential value of dapagliflozin in patients with severe heart failure (HF). Finally, Dr. Eagle explores non-pharmacologic therapies to reduce morbidity and improve function in HF patients.   Subscribe to Eagle’s Eye View  

Discover the optimal threshold for identifying myocardial infarctions after PCI. Unravel the intriguing prognostic features of myocardial fibrosis in patients with severe aortic valve stenosis. Delve into the complex relationship between anticoagulation, bleeding risks, and cancer diagnoses. This discussion highlights how troponin levels and bleeding events can significantly impact patient outcomes. Tune in for cutting-edge insights into these critical cardiovascular topics!

Discover the intriguing potential of SGLT2 inhibitors to slow down aortic valve stenosis progression. Delve into the debate over whether early or late ablation is more beneficial for managing atrial fibrillation. Plus, learn about the new guidelines for athletes with cardiac abnormalities, emphasizing the importance of collaborative decision-making for safe sports participation.

Get ready for an insightful journey into cardiology! The discussion kicks off with fascinating insights on arrhythmia recurrence following catheter ablation for atrial fibrillation. Next, the long-term benefits of tafamidis in treating transthyretin amyloid cardiomyopathy are thoroughly examined. Rounding it off, the impact of sodium restriction on blood pressure is analyzed, highlighting key findings from a recent population study. Tune in for a blend of cutting-edge research and practical implications!

Delve into the latest advancements in postpartum hypertension and how tighter blood pressure control can transform outcomes for new mothers. Discover the role of beta blocker therapy in addressing Takotsubo syndrome, offering hope for those affected. The conversation also turns to the global landscape of secondary prevention, highlighting the significant gaps in medication adherence and the need for improved practices worldwide.

Explore the latest advancements in cardiac rehabilitation tailored for heart failure patients. Discover how cancer survivors can effectively manage their cardiovascular health after treatment. The discussion also covers the pros and cons of bioprosthetic versus mechanical aortic valve replacements for younger patients, shedding light on the best options for improved health outcomes.

Discover the fascinating world of cost-effectiveness in polypills and their potential impact on vulnerable populations. Delve into the challenges of managing obesity in patients with familial hyperlipidemia, shedding light on their unique health risks. The discussion also uncovers alarming connections between adverse pregnancy outcomes and long-term heart failure risks, emphasizing the importance of cardiovascular health throughout life.